AMSURG launches nationwide campaign to spotlight rising colon cancer rates, urges early screening

Editor's Note

As Colon Cancer Awareness Month begins, AMSURG—a leading provider of ambulatory surgery center (ASC) services and GI care—has launched an educational push to boost colonoscopies and reduce soaring colon cancer rates, particularly among younger adults, a March 3 press release reports. The campaign highlights the lifesaving impact of early detection and aims to break down barriers to screening through innovative partnerships, improved education, and enhanced access.

“Colon cancer is preventable with appropriate screening and highly treatable when detected early, and yet it remains the second leading cause of cancer death,” said AMSURG Chief Clinical Officer Abbey Vandersall, MD, MS, citing the American Cancer Society. AMSURG supports more than one million colonoscopy patients each year and partners with over 1,300 GI physicians nationwide. These specialists are on the frontline of colon cancer prevention—identifying precancerous polyps, diagnosing colon cancer, and guiding treatment. By collaborating with GI professionals and pushing for greater awareness, the company seeks to reduce colon cancer deaths and encourage individuals to consult a physician about when to be screened.

A colonoscopy remains the gold-standard test for early colon cancer detection, enabling physicians to thoroughly examine the colon and remove polyps before they develop into a greater threat. Those experiencing symptoms or needing guidance about screening timelines are encouraged to seek advice from a healthcare provider. More information can be found at StopColonCancerNow.com.